Anti-Cancer Oncology By Dolphin Pharma
Dolphin Pharma offers a specialized range of Anti-Cancer & Oncology products developed to support modern cancer treatment needs. Our oncology medicines are formulated with a strong focus on quality, safety, and therapeutic effectiveness. We aim to support healthcare professionals with reliable solutions across different stages of cancer care. Each product reflects our commitment to consistent and responsible pharmaceutical manufacturing.
Lenalid 5 mg
Generic Name: Lenalidomide
Ninlib 150 mg
Generic Name: Nilotinib
Tasigna 150 mg
Generic Name: Nilotinib
Xbira 250 mg
Generic Name: Abiraterone Acetate
Abstet 250 mg
Generic Name: Abiraterone Acetate
Abione 250 mg
Generic Name: Abiraterone Acetate
Abirapro 250 mg
Generic Name: Abiraterone Acetate
Bdron 250 mg
Generic Name: Abiraterone Acetate
MyTera 250 mg
Generic Name: Abiraterone Acetate
Zecyte 250 mg
Generic Name: Abiraterone Acetate
Adriamycin 50 mg
Generic Name: Doxorubicin Hydrochloride
Duxocin 10 mg
Generic Name: Doxorubicin Hydrochloride
Xovoltib 30 mg
Generic Name: Afatinib Dimaleate
Afanat 20 mg
Generic Name: Afatinib
Alkacel 2 mg
Generic Name: Melphalan
Anastronat 1 mg
Generic Name: Anastrozole
Arimidex 1 mg
Generic Name: Anastrozole
Anatero 1 mg
Generic Name: Anastrozole
Femistra 1 mg
Generic Name: Anastrozole
Anaday 1 mg
Generic Name: Anastrozole
Cancer treatment requires accuracy, consistency, and high-quality pharmaceutical support. At Dolphin Pharma, our Anti-Cancer & Oncology product range is developed to meet the growing need for dependable cancer treatment solutions. This category includes a variety of oncology medicines used in the treatment and management of different types of cancer, helping healthcare providers deliver effective and well-structured treatment plans. Dolphin Pharma understands the critical role oncology medicines play in patient care. Our Anti-Cancer products are manufactured under strict quality control systems and comply with applicable pharmaceutical standards. Each formulation is designed to maintain product stability, safety, and therapeutic reliability. Our goal is to support healthcare professionals with oncology medicines they can trust for consistent performance. The Anti-Cancer & Oncology medicines offered by Dolphin Pharma are commonly used in chemotherapy support, targeted cancer therapy, and supportive oncology care. These products help manage disease progression, control abnormal cell growth, and assist in improving overall treatment outcomes when prescribed by qualified medical professionals. We continuously work toward improving our formulations through research-driven and ethical pharmaceutical practices. Our oncology product portfolio is suitable for hospitals, oncology centers, clinics, and pharmaceutical distributors seeking reliable cancer treatment medicines. Dolphin Pharma ensures proper packaging, clear labeling, and adherence to regulatory guidelines, making our products suitable for both domestic and international healthcare markets. We also focus on maintaining supply consistency, which is essential for uninterrupted cancer treatment. In addition to product quality, Dolphin Pharma emphasizes responsible service and long-term partnerships. Cancer care often requires sustained therapy, and timely availability of medicines is crucial. Our team works closely with distribution partners to ensure smooth supply chain management and dependable support. With the global rise in cancer cases, the demand for effective and trustworthy oncology medicines continues to grow. The Anti-Cancer & Oncology category by Dolphin Pharma reflects our commitment to contributing positively to cancer care through quality-driven pharmaceutical solutions. By maintaining high standards, focusing on patient safety, and supporting healthcare professionals, Dolphin Pharma aims to be a trusted name in oncology treatment support.